Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
Researchers:
Have you heard a story, statistic, or discovery that might interest the public? Let us know about it!
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Macular Degeneration Research - Current Award

Photo Pending

Rajendra Apte, M.D., Ph.D.

Washington University, School of Medicine
Saint Louis, MO

Title: The importance of macrophage senescence in regulating angiogenesis in macular degeneration
Non-Technical Title: Effect of cholesterol on the aged immune system in macular degeneration

Duration: April 1, 2010 - March 31, 2012
Award Type: Standard
Award Amount: $100,000


Summary:

How does cholesterol within drusen influence macrophage function in age-related macular degeneration? Does it promote the conversion of macrophages to pro-angiogenic cells that, in turn, cause progression to neovascular disease?

Details:

Our proposal will address whether cholesterol in drusen seen during the early stages of macular degeneration causes dysfunctional activation of macrophages and advancement to neovascular age-related macular degeneration (AMD). We will use morphologic (structural), functional, and genetic approaches to test this hypothesis.

Public Health Relevance: Age-related macular degeneration is the leading cause of blindness in people over 50 years of age. Mechanisms that lead to immune dysfunction as identified in this proposal that are relevant to the pathophysiology of abnormal angiogenesis will help us devise immune based therapies that ameliorate disease progression and ultimately blindness.

Although epidemiologic studies suggest that statins that lower cholesterol reduce the risk of progression in AMD, our study is unique in that it directly evaluates the role of cholesterol within drusen during the progression of AMD.